肝纤维化治疗研究的现状
摘要
肝纤维化是肝脏对各种原因所致肝损伤的修复反应,特征性表现为肝内细胞外基质(ECM)过度合成、沉积,是慢性肝病发展为肝硬化的中间过程。由于肝纤维化早期是可逆的,而肝硬化是不可逆的,阻断、抑制或逆转肝纤维化是治疗慢性肝病的一个十分重要的手段。肝纤维化的形成涉及诸多环节和因素,因而衍生了方式各异的抗肝纤维化治疗方案。现对近年治疗肝纤维化现状做一综述。
出处
《中国医师进修杂志(内科版)》
2008年第2期72-74,共3页
Chinese Journal of Postgraduates of Medicine
参考文献21
-
1Bataller R,Brenner DA. Liver fibrosis. J Clin Invest,2005,115 (2):209-218.
-
2Hirose A,Ono M,Saibara T,et al. Angiotensin Ⅱ type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology, 2007,45 (6) : 1375-1381.
-
3Liu X, Hu H, Yin JQ. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int,2006,26( 1 ) : 8-22.
-
4Zou WL,Yang Z,Zang YJ,et al. Inhibitory effects of prostaglandin E1 on activation of hepatic stellate cells in rabbits with schistosomiasis. Hepalobiliary Pancreat Dis lnt,2007,6 (2): 176-181.
-
5Mathew TC,Abdeen S,Dashti H,et al. Effect of alpha-interferon and alpha-tocopherol in reversing hepatic cirrhosis in rats. Anal Histol Embryol, 2007,36( 2 ) : 88-93.
-
6Lee TF,Lin YL,Huang YT. Studies on antiproliferative effects of phthalides from IAgusticum chuanxiong in hepatic steUate cells. Planta Med, 2007,73 ( 6 ) : 527-534.
-
7Hsu YC, Chiu YT, Cheng CC, et al. Antifibrotic effects of tetrandrine on hepatic steUate cells and rats with liver fibrosis. J Gastroenterol Hepatol, 2007,22( 1 ) : 99-111.
-
8Zhang C,Zhu Y,Wan J,et al. Effects of Ginkgo biloba extract on cell proliferatlon,cytokines and exlxacellular matrix of hepatic stellate cells. Liver Int,2006,26( 10): 1283-1290.
-
9Utsunomiya T, Okamoto M, Hashimoto M, et al. A gene-expression signature can quantify the degree of hepatic fibrosis in the rat. J Hepatol, 2004,41 ( 3 ) : 399--406.
-
10Chou WY,Lu CN,Lee TH,et gene transfer ameliorates carbon al. Electroporatlve interleukin-10 fibrosis by MMP and TIMP modulation. 2006,27( 4 ) : 469-476. murine liver
-
1穆洪举.膝关节发生“骨质增生”怎么办[J].大家健康,2016,0(11):21-21.
-
2李宁,周蓉蓉,张明,董全江,战淑慧.幽门螺杆菌感染患者胃癌及癌旁组织中hMSH2蛋白的表达特点[J].浙江医学,2007,29(9):982-983. 被引量:1
-
3君荣.骨刺——人体的修复反应[J].健康必读,2005(8):31-32.
-
4程明亮,周明玉.中医药防治肝纤维化[J].中华中医药杂志,2011,26(12):2761-2765. 被引量:15
-
5林昶.中药抗肾纤维化研究进展[J].湖南中医杂志,2008,24(1):95-97. 被引量:4
-
6吴惠春,张斌.姜黄素抗肝纤维化机制研究进展[J].中国中西医结合杂志,2013,33(1):135-137. 被引量:10
-
7李鸿彬,陆文亮.对中药仿制“同”的思考[J].中国药事,2011,25(7):674-677.
-
8曹秋彩,王单一,薛瑞.中医药在抗肾纤维化中防治机制的研究进展[J].河南中医学院学报,2006,21(6):85-87. 被引量:8
-
9王珊珊,崔宝娟,孙强三.生长因子与神经肽促进骨折愈合的研究进展[J].中华物理医学与康复杂志,2008,30(5):345-348. 被引量:3
-
10冀霞,赵昭性,陈宁荻.异甘草酸镁抗乙型肝炎病毒致肝纤维化的疗效观察[J].山西医药杂志(下半月),2010,39(1):71-72. 被引量:2